Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.

Ghosh S, Singh R, Goap TJ, Sunnapu O, Vanwinkle ZM, Li H, Nukavarapu SP, Dryden GW, Haribabu B, Vemula PK, Jala VR

DOI: 10.1186/s12951-024-02990-8
Published: 2024 Nov 13
Container: Journal of nanobiotechnology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12951-024-02990-8,
  title = {Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.},
  author = {Ghosh S and Singh R and Goap TJ and Sunnapu O and Vanwinkle ZM and Li H and Nukavarapu SP and Dryden GW and Haribabu B and Vemula PK and Jala VR},
  year = {2024},
  journal = {Journal of nanobiotechnology},
  doi = {10.1186/s12951-024-02990-8},
  url = {https://doi.org/10.1186/s12951-024-02990-8}
}

RIS

TY  - JOUR
TI  - Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.
AU  - Ghosh S
AU  - Singh R
AU  - Goap TJ
AU  - Sunnapu O
AU  - Vanwinkle ZM
AU  - Li H
AU  - Nukavarapu SP
AU  - Dryden GW
AU  - Haribabu B
AU  - Vemula PK
AU  - Jala VR
PY  - 2024
JO  - Journal of nanobiotechnology
DO  - 10.1186/s12951-024-02990-8
UR  - https://doi.org/10.1186/s12951-024-02990-8
ER  -

APA

S, G., R, S., TJ, G., O, S., ZM, V., H, L., SP, N., GW, D., B, H., PK, V., & VR, J. (2024). Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.. Journal of nanobiotechnology. https://doi.org/10.1186/s12951-024-02990-8

Source records

pubmed · retrieved 2026-09-26T12:11:45.352Z